Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Comment by Skateron Nov 02, 2017 7:24pm
61 Views
Post# 26897750

RE:RE:RE:RE:Pharma Strategic Investment

RE:RE:RE:RE:Pharma Strategic InvestmentThanks for the reply.  Wasn't sure if you thought they were great or not. 

I am in agreement with your assessment, stock has lagged peers, and volume is considerably less than others.  I still maintain had they come out at $3-5 we'd still be where we are now only we would have more than doubled.  As to who made the call on that and valuation support over the past year, hard to say. 

I think CanniMed has a good story, thats why I picked it over Canopy, but have to give respect where respect is due and Canopy has and continues to perform.  Maybe they're deal junkies but they are now the unchallenged leader, a spot that Cannimed could have? should have? held but didn't.  Just feels like CanniMed is moving too slow, but I don't know all the inner workings.  I am impressed by the talent that Canopy continues to add, sure wish CanniMed followed suit, you have to have good people with the right experience to play in this emerging industry.  And a big warchest.  >$300 million, another $250 million in warrants, f-me that is a lot of money.  Rumor is Canopy will take a run at Aphria, that would prove to be quite interesting.  

At least we gained some value this last week, lets hope the trend continues.

Skater
<< Previous
Bullboard Posts
Next >>